Anti-HIV-1 gp120 Recombinant Antibody (BAT085) (CAT#: MRO-134LC)

This product is a recombinant mouse anti-HIV-1 monoclonal antibody (BAT085). BAT085 specifically binds to CD4 binding site of gp120 and can be potentially used in the treatment studies of acquired immunodeficiency syndrome (AIDS), a condition in humans characterized by clinical features including wasting syndromes, central nervous system degeneration and profound immunosuppression that results in life-threatening opportunistic infections and malignancies.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA
ELISA

Figure 1 mAb-induced gpl20 dissociation.

Figure 1 mAb-induced gpl20 dissociation.

The cells were pelleted, and the supernatant was spun through 0.22-/xm filters to remove cell debris and treated with NP-40, 1% final concentration. Gp120-mAb complexes in the supernatants were then denatured to prevent interference of gp120 detection by bound Ig, and gp120 concentration was measured by ELISA. Each bar represents the mean signal obtained from duplicate ELISA wells, and the dotted line represents the level of spontaneous gpl20 dissociation.

Human Immunodeficiency Virus Type 1 Neutralization Is Determined by Epitope Exposure on the gp120 Oligomer

ELISA

Figure 2. Inhibition of the binding of biotinylated BAT085 (△) to captured HIV-1 IIIB gpl20 in ELISA.

Figure 2. Inhibition of the binding of biotinylated BAT085 (△) to captured HIV-1 IIIB gpl20 in ELISA.

Fung, M. S., Sun, C. R., Gordon, W. L., Liou, R. S., Chang, T. W., Sun, W. N., ... & Ho, D. D. (1992). Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120. Journal of virology, 66(2), 848-856.

Neut

Figure 3 mAb neutralization of HIV-1.

Figure 3 mAb neutralization of HIV-1.

A stock of virus previously titered on HeLa-CD4-LTR LacZ cells and known to give 200 infected cells/well in 20/zl was incubated for 2 h with mAbs at the concentrations shown in the figure before washing and trypsinization to remove noninternalized virions. The cells were subsequently cultured for 24 h at 37~ before fixation and staining with X-Gal for 4 h at 37~ The cells were then fixed overnight, and the blue loci were counted by eye under magnification. Each point represents the mean of triplicate wells, and the vertical bars indicate +_ 1 SD.

Human Immunodeficiency Virus Type 1 Neutralization Is Determined by Epitope Exposure on the gp120 Oligomer

Neut

Figure 4 is a plot showing the relative effectiveness of four of the monoclonal antibodies of the invention in neutralizing HIV-1 infection of H9 cells.

Figure 4 is a plot showing the relative effectiveness of four of the monoclonal antibodies of the invention in neutralizing HIV-1 infection of H9 cells.

The percentage of infected cells was determined thirteen days after infection.


Specifications

  • Host Species
  • Mouse
  • Type
  • Mouse antibody
  • Specificity
  • HIV-1
  • Clone
  • BAT085
  • Applications
  • ELISA, WB, IF, Neut
  • Related Disease
  • AIDS

Applications

  • Application Notes
  • The HIV-1 gp120 antibody has been reported in applications of Enzyme-linked Immunosorbent Assay, Western Blot, Immunofluorescence, Neutralization.

Target

  • Alternative Names
  • Human immunodeficiency virus type 1; HIV-1; Envelope glycoprotein GP120; gp120; HIV envelope

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone BAT085"

See other products for "HIV-1 gp120"

Single-domain Antibody

Mouse Antibody

CAT Product Name Application Type
MRO-132LC Anti-HIV-1 gp120 Recombinant Antibody (BAT123) ELISA, WB, IF, Neut Mouse antibody
MRO-133LC Anti-HIV-1 gp120 Recombinant Antibody (BAT267) ELISA, WB, Neut Mouse antibody
MRO-150LC Anti-HIV-1 gp120 Recombinant Antibody (G3-4) ELISA, Inhib, FC, Neut, RIPA, DB, IP Mouse antibody
MRO-152LC Anti-HIV-1 gp120 Recombinant Antibody (G3-136) Neut, ELISA Mouse antibody
MRO-041LC-F(E) Anti-HIV-1 gp120 Recombinant Antibody Fab Fragment (D59/A2) ELISA Mouse antibody

Chimeric Antibody

CAT Product Name Application Type
MRO-135LC Anti-HIV-1 gp120 Recombinant Antibody (CAG1-51-4) ELISA, WB, Neut Chimeric antibody (mouse/human)
MRO-135LC-S(P) Anti-HIV-1 gp120 Recombinant Antibody scFv Fragment (CAG1-51-4) ELISA, WB Chimeric antibody (mouse/human)
MRO-135LC-F(E) Anti-HIV-1 gp120 Recombinant Antibody Fab Fragment (CAG1-51-4) ELISA, WB Chimeric antibody (mouse/human)

Rabbit Monoclonal Antibody

CAT Product Name Application Type
MOR-4220 Rabbit Anti-HIV-1 gp120 Recombinant Antibody (clone SI299DS) WB, ELISA Rabbit IgG

Humanized Antibody

CAT Product Name Application Type
PABX-101-S(P) Human Anti-HIV-1 gp120 Recombinant Antibody (clone PG9); scFv Fragment WB, ELISA, FuncS Human scFv

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for MRO-134LC. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare